ArticlePolymers2026
Successive Self-Nucleation and Annealing for the Characterization of Biomedical Ultra-High-Molecular-Weight PolyEthylene (UHMWPE) Formulations.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Successive Self-Nucleation and Annealing (SSA) technique is a thermal fractionation method that involves subjecting a polymer sample to sequential self-nucleation and annealing steps at progressively decreasing temperatures, using differential scanning calorimetry (DSC). Since its introduction in the late 1990s, SSA has been widely applied to study the molecular structure of polymers with structural irregularities, including highly branched or crosslinked polyethylenes and random copolymers. However, the use of SSA for medical-grade ultra-high-molecular-weight polyethylene (UHMWPE), a highly linear homopolymer with minimal defects, has not yet been explored. This study aims to evaluate both its applicability to biomedical UHMWPE and its ability to reveal morphological differences among commercially available formulations. Several biomedical UHMWPE formulations, including conventional, highly cross-linked, and α-tocopherol-stabilized materials, were characterized by micro-FTIR, gel fraction and cross-link density measurements and subsequently subjected to SSA thermal fractionation. The results show that ram extrusion induces entanglements that act as interruptions in the otherwise linear chain structure, thereby enabling thermal fractionation: more than 80% of the crystalline fraction of ram-extruded UHMWPE is composed of three crystal populations melting at approximately 135, 132, and 126 °C, accompanied by four additional minor fractions at progressively lower melting temperatures. Gamma irradiation followed by thermal treatments significantly modifies the fractionation behavior, leading to the formation of an additional population of high-melting crystallites as evidenced by an increase in the number of melting peaks from 7 to 8. Oxidative degradation of highly crosslinked and annealed UHMWPE increases crystallinity by approximately 11% relative to its unoxidized counterpart but reduces the ability of the material to undergo thermal fractionation, decreasing the number of melting peaks. In contrast, the addition of low concentrations of α-tocopherol does not significantly influence the fractionation behavior. These findings demonstrate that thermal fractionation of medical-grade UHMWPE is feasible and that SSA is an effective tool for detecting morphological differences among formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.